PULMOPHARMA ApS

CVR 36428023 · Private limited company (ApS) · Active · Low risk

PULMOPHARMA ApS is a Private limited company (ApS), founded on , based in Ebeltoft. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 11 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 11.4m and a net result of DKK -49k. CEO: Dan Mønster Nielsen.

Bankruptcy risk for PULMOPHARMA ApS

0.1%
probability of bankruptcy within 12 months
Low risk

0.1 × the average (1.41%) · higher risk than 38% of active Danish companies

Lowest riskHighest risk

Increases the risk

CEO's previous bankruptcies1 · bankruptcy rate 14.2%1.6×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Annual reports filed late1 · bankruptcy rate 11.3%1.3×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Share of late annual reports0.01%–25% · bankruptcy rate 4.5%0.51×
Negative equityNo · bankruptcy rate 5.1%0.58×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
36428023
Status
Active
Company type
Private limited company (ApS)
Founded
(12 years)
Address
c/o Dan Mønster Nielsen, Bøgebjerg 2, 2. 4
8400 Ebeltoft
Municipality
Syddjurs
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 48k
Auditor
J H REGNSKAB V/JAN EKMANN HØRSEL
Audit opted out
Yes

Warning signs

Annual reports filed late1 of 11
Missing annual reportNo
Negative equityNo
Equity ratio84.2%
Current ratio178%
Moves (last 2 years)0
CEO changes in total2
CEO's previous bankruptcies1
Other companies at the address9
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -49kDKK -20k
Net profitDKK -49kDKK -20k
EquityDKK 11.4mDKK 7.4m
Total assetsDKK 13.6mDKK 9.3m
CashDKK 2.5m–
Short-term debtDKK 2.1m–
Tax owedDKK 0–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · J H REGNSKAB V/JAN EKMANN HØRSEL.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025180
1 Jan 2024 – 31 Dec 2024169
1 Jan 2023 – 31 Dec 2023177
1 Jan 2022 – 31 Dec 2022174
1 Jan 2021 – 31 Dec 2021177
1 Jan 2020 – 31 Dec 2020181
1 Jan 2019 – 31 Dec 2019247 Late
1 Jan 2018 – 31 Dec 201849
1 Jan 2017 – 31 Dec 2017115
1 Jan 2016 – 31 Dec 2016151
1 Nov 2014 – 31 Dec 2015163

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEODan Mønster NielsenCurrent
CEOPer Bendix Jeppesen
CEOTorben Ballegaard Sørensen
BoardPer Bendix JeppesenCurrent
BoardDan Mønster NielsenCurrent
BoardPeter Frithjof BangCurrent
BoardTorben Ballegaard SørensenCurrent
Owner (25%)PETER BANG HOLDING ApSCurrent
Owner (20%)LARS NYENSTAD ApSCurrent
Owner (20%)BENDIX-HOLDING ApSCurrent
Owner (20%)LouMar ApSCurrent
Owner (33%)Per Bendix Jeppesen
Owner (33%)Dan Mønster Nielsen
Owner (33%)Torben Ballegaard Sørensen
Owner (33%)LARS NYENSTAD ApS
Owner (33%)LouMar ApS
Owner (33%)BENDIX-HOLDING ApS
Owner (10%)PETER BANG HOLDING ApS
Owner (25%)LARS NYENSTAD ApS
Owner (25%)BENDIX-HOLDING ApS
Owner (25%)LouMar ApS
FounderPer Bendix JeppesenCurrent
FounderDan Mønster NielsenCurrent
FounderTorben Ballegaard SørensenCurrent

The CEOs' other companies

Dan Mønster Nielsen – 7 other companies, of which 1 bankrupt

Per Bendix Jeppesen – 7 other companies, of which 2 bankrupt

Torben Ballegaard Sørensen – 59 other companies, of which 1 bankrupt

Address history (2 moves)

c/o Dan Mønster Nielsen, Bøgebjerg 2, 2. 4, 8400 Ebeltoft
c/o Dan Mønster Nielsen, Bøgebjerg 1, 2. 2, 8400 Ebeltoft
Parkboulevarden 31, 8920 Randers NV

Former names

PULMOPHARMA ApS – now
PULMOPHARMA IVS –

Other companies at the same address

Similar companies in Syddjurs

Questions and answers about PULMOPHARMA ApS

Has PULMOPHARMA ApS gone bankrupt?

No, PULMOPHARMA ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of PULMOPHARMA ApS?

Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.

Who is the CEO of PULMOPHARMA ApS?

Dan Mønster Nielsen is the CEO of PULMOPHARMA ApS.

Who is the auditor of PULMOPHARMA ApS?

PULMOPHARMA ApS most recently used J H REGNSKAB V/JAN EKMANN HØRSEL.

When was PULMOPHARMA ApS founded?

PULMOPHARMA ApS was founded on 1 November 2014.

What is the equity of PULMOPHARMA ApS?

Equity was DKK 11.4m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.